Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease

2013214 citationsJournal Articlehybrid Open Access

Authors

Yaling Han · General Hospital of Shenyang Military Region

Guoying Zhu · Wuhan University

Han Lixian · Cangzhou Central Hospital

Fengxia Hou · Changchun Obstetrics and Gynecology Hospital

Weijian Huang · Wenzhou Medical University

Huiliang Liu · Chinese People's Armed Police General Hospital

Jihong Gan

Abstract

Rosuvastatin significantly reduced the risk of CI-AKI in patients with DM and CKD undergoing arterial contrast medium injection. (Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes [TRACK-D]; NCT00786136).

Topics & Keywords

Acute Kidney Injury Research Chronic Kidney Disease and Diabetes Cardiac Imaging and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American College of Cardiology

Volume 63, Issue 1, pp. 62-70

DOI: 10.1016/j.jacc.2013.09.017

Field-Weighted Citation Impact: 15.66